Stocks and Investing
Stocks and Investing
Fri, April 26, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Etzer Darout Maintained (AZN) at Buy with Increased Target to $82 on, Apr 26th, 2024
Etzer Darout of BMO Capital, Maintained "AstraZeneca PLC" (AZN) at Buy with Increased Target from $80 to $82 on, Apr 26th, 2024.
Etzer has made no other calls on AZN in the last 4 months.
There are 4 other peers that have a rating on AZN. Out of the 4 peers that are also analyzing AZN, 3 agree with Etzer's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Emmanuel Papada of "Deutsche Bank" Upgraded from Strong Sell to Hold on, Tuesday, April 16th, 2024
- Emmanuel Papadakis of "Deutsche Bank" Downgraded from Strong Buy to Hold on, Thursday, February 8th, 2024
- Peter Welford of "Jefferies" Downgraded from Strong Buy to Hold on, Wednesday, January 3rd, 2024
This is the rating of the analyst that currently disagrees with Etzer
- Mark Purcell of "Morgan Stanley" Initiated at Buy and Held Target at $85 on, Tuesday, January 23rd, 2024
Contributing Sources